Get the tools used by (smart)2 investors.

Consensus Net Income, Actual for Inozyme Pharma Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

INZY: Inozyme Pharma Inc

Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The compan...

0.97 USD
Price
USD
Fair Value
Upside
0.92 - 7.79
52-week range

Analysis

Benchmarks

Metric Usage: Consensus Net Income, Actual

Hide this widget
ni_actual
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Consensus Net Income, Actual in the forecast category include:

View Full List

Search for metric or datapoint

Consensus Net Income, Actual

Reported net income including any adjustments for unusual items proposed by management. This metric is useful for analyst forecast vs actual analysis ...

Definition of Consensus Net Income, Actual

Sector Benchmark Analysis

All rights reserved. Terms Of Use